한빛사논문, 상위피인용논문
Abstract
1 Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA
2 Department of Medicine, Harvard Medical School, Boston, MA 02115, USA
3 Department of Genetics, Harvard Medical School, Boston, MA 02115, USA
4 Department of Pathology, Brigham and Women''s Hospital, Harvard Medical School, Boston, MA 02115, USA
5 Center for Applied Cancer Science, Belfer Foundation Institute for Innovative Cancer Science, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA
6 Department of Statistics, Harvard University, Cambridge, MA 02138, USA
7 Division of Hematology, Department of Medicine, Brigham and Women''s Hospital, Boston, MA 02115, USA
8 Department of Dermatology, Harvard Medical School, Boston, MA 02115, USA
9 Department of Statistics, Stanford University, Stanford, CA 94305, USA
10 Department of Pathology and Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical School, Dallas, TX 75390, USA
*Corresponding author
Diego H. Castrillon
*Corresponding author
Ronald A. DePinho
Activated phosphoinositide 3-kinase (PI3K)-AKT signaling appears to be an obligate event in the development of cancer. The highly related members of the mammalian FoxO transcription factor family, FoxO1, FoxO3, and FoxO4, represent one of several effector arms of PI3K-AKT signaling, prompting genetic analysis of the role of FoxOs in the neoplastic phenotypes linked to PI3K-AKT activation. While germline or somatic deletion of up to five FoxO alleles produced remarkably modest neoplastic phenotypes, broad somatic deletion of all FoxOs engendered a progressive cancer-prone condition characterized by thymic lymphomas and hemangiomas, demonstrating that the mammalian FoxOs are indeed bona fide tumor suppressors. Transcriptome and promoter analyses of differentially affected endothelium identified direct FoxO targets and revealed that FoxO regulation of these targets in vivo is highly context-specific, even in the same cell type. Functional studies validated Sprouty2 and PBX1, among others, as FoxO-regulated mediators of endothelial cell morphogenesis and vascular homeostasis.
Footnotes
11 These authors contributed equally to this work.
논문정보
관련 링크
관련분야 연구자보기
소속기관 논문보기
관련분야 논문보기
해당논문 저자보기